Prevalence and characterization of opportunistic candidal infections among patients with pulmonary tuberculosis

Journal of Oral and Maxillofacial Pathology

Volumn 20, Issue 2, 2016, Pages 183-189

  Astekar, Madhusudan ^a   Bhatiya, Priyanka Sharma ^b   Sowmya, G V ^c  

^a Pacific Academy of Higher Education and Research   (India)

^b Private Dental Practitioner   (India)

^c INSTITUTE OF DENTAL SCIENCES   (India)

Author keywords

Antifungal drugs; Candida; ChromAgar; opportunistic infections; pulmonary tuberculosis

Indexed keywords

EID: 84979529308     PISSN: 0973029X     EISSN: 1998393X     Source Type: Journal    
DOI: 10.4103/0973-029X.185913     Document Type: Article

References (21)

1. De Backer AI, Mortelé KJ, De Keulenaer BL, Parizel PM. Tuberculosis: Epidemiology, manifestations, and the value of medical imaging in diagnosis. JBR-BTR 2006;89:243-50.
2. Chakraborty AK. Epidemiology of tuberculosis: Current status in India. Indian J Med Res 2004;120:248-76.
3. Naz SA, Tariq P. A study of the trend in prevalence of opportunistic candidal co-infections among patients of pulmonary tuberculosis. Pak J Bot 2004;36:857-62.
4. Pang SC. Opportunistic infections of the respiratory tract. Bull Hong Kong Med Assoc 1973;25:69-82.
5. Segal E, Elad D. Topley and Wilson's Microbiology and Microbial Infections. 10th ed.. Edinburg: Edward Arnold; 2005. p. 579-94.
6. Nadeem SG, Hakim ST, Kazmi SU. Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings. Libyan J Med 2010;5: e2144 DOI: 10.3402/ ljm.v5i0.2144.
7. Khanna BK, Nath P, Ansari AH. A study of mycotic flora of respiratory tract in pulmonary tuberculosis. Indian J Tuberc 1977;24:159-62.
8. Brooks FG, Butel JS, Morse SA. Jawetz Melnick and Adeberg's Medical Microbiology. 3rd ed.. Singapore: McGraw Hill; 2004. p. 645-51.
9. Baradkar VP, Mathur M, Wanjari K, Kumar S. Candida in pulmonary tuberculosis. Bombay Hosp J 2009;Special issue:52-3.
10. Shome SK, Upreti HB, Singh MM, Pamra SP. Mycoses associated with pulmonary tuberculosis. Indian J Tuberc 1976;23:64-8.
11. Panda BN. Fungal infections of lungs: The emerging scenario. Indian J Tuberc 2004;51:63-9.
12. Fotedar R, Hedaithy SS. Identification of chlamydospore-negative Candida albicans using chromagar Candida medium. Mycoses 2003;46:96-103.
13. Latha R, Sasikala R, Muruganandam N, Babu V. Study on the shifting patterns of non Candida albicans Candida in lower respiratory tract infections and evaluation of the chromagar in identification of the Candida species. J Microbiol Biotech Res 2011;1:113-9.
14. Jain SK, Agrawal RL, Sharma DA, Agrawal M. Fungal superinfection in pulmonary tuberculosis. Indian J Tuberc 1982;29:173-8.
15. Riddell RW, Clayton YM. Pulmonary mycoses occurring in Britain. Br J Tuberc 1958;51:34-44.
16. Cermeno V, Julmery YV, Julman CR. Systemic mycosis associated to tuberculosis in Bolivar state, Venezuela. Kasmera 2008;36:39-44.
17. Randhawa HS. Respiratory and systemic mycoses: An overview. Indian J Chest Dis Allied Sci 2000;42:207-19.
18. Meurman JH, Siikala E, Richardson M, Rautemaa R. Non-Candida albicans Candida yeasts of the oral cavity. In: A. Mendez-Vilas editor. Communicating Current Research and Educational Topics and Trends in Applied Microbiology. Badajoz (Spain):Formatex; 2007. p. 719-31.
19. Bouchara JP, Declerck P, Cimon B, Planchenault C, de Gentile L, Chabasse D. Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations. Clin Microbiol Infect 1996;2:202-8.
20. Chaudhari SK. Concise Medical Physiology. 6th ed.. India: New Cental Book Agency; 2008. p. 57-9.
21. Jha BK, Dey S, Tamang MD, Joshy ME, Shivananda PG, Brahmadatan KN. Characterization of Candida species isolated from cases of lower respiratory tract infection. Kathmandu Univ Med J 2006;4:290-4.